Olinger Haydee 4

4 · TRANSACT TECHNOLOGIES INC · Filed Mar 2, 2026

AI-generated summary of this filing

Updated Mar 2, 2026

TransAct Technologies (TACT) Director Haydee Olinger Receives 7,375 Shares

What Happened

Haydee Olinger, a director of TransAct Technologies, had restricted stock units (RSUs) convert into 7,375 shares of common stock over four dates (Feb 27, 2026; Feb 28, 2026; Mar 1, 2026; Mar 2, 2026). The Form 4 lists these as derivative conversions (transaction code M). No exercise prices or cash amounts are reported (N/A), because these were RSU vesting/conversions rather than open‑market purchases or sales.

Key Details

Transaction dates and quantities: 2/27/2026: 2,850 shares; 2/28/2026: 1,675 shares; 3/1/2026: 1,600 shares; 3/2/2026: 1,250 shares — total 7,375 shares.
Transaction code: M (exercise or conversion of derivative security). Prices and dollar values: N/A (conversion of RSUs to common stock, one‑for‑one).
Filing date: 2026-03-02 (filed timely based on the reported transaction dates).
Shares owned after transaction: not disclosed in the filing.
Footnotes: F1–F4 show these were RSUs granted in 2022–2025 under the company’s equity incentive plan, vesting 25% annually and converting 1:1 to common stock when vested.
The Form shows both “acquired” (underlying shares) and “disposed” (the derivative RSU being settled) entries — the “disposed” entries reflect the RSU being converted, not a sale for cash.

Context

This was a routine compensation event (vested RSUs converting into shares), not an open‑market purchase or sale. There is no cashless exercise/sale reported — no proceeds were listed. For retail investors, RSU vesting increases insider shareholdings but is typically part of standard compensation and not necessarily a directional signal about the insider’s view of the stock.

Form 4

Period: 2026-02-27

Director

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-02-27+2,850→ 30,035 total
Exercise/Conversion
Common Stock
[F2]
2026-02-28+1,675→ 31,710 total
Exercise/Conversion
Common Stock
[F3]
2026-03-01+1,600→ 33,310 total
Exercise/Conversion
Common Stock
[F4]
2026-03-02+1,250→ 34,560 total
Exercise/Conversion
Restricted Stock Units
[F1]
2026-02-27−2,850→ 8,550 total
→ Common Stock (2,850 underlying)
Exercise/Conversion
Restricted Stock Units
[F2]
2026-02-28−1,675→ 3,350 total
→ Common Stock (1,675 underlying)
Exercise/Conversion
Restricted Stock Units
[F3]
2026-03-01−1,600→ 1,600 total
→ Common Stock (1,600 underlying)
Exercise/Conversion
Restricted Stock Units
[F4]
2026-03-02−1,250→ 0 total
→ Common Stock (1,250 underlying)

Footnotes (4)

[F1]Restricted Stock Units issued on February 27, 2025 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary of the date of grant that have converted to common stock on a one-for-one basis.
[F2]Restricted Stock Units issued on February 29, 2024 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary of the date of grant that have converted to common stock on a one-for-one basis.
[F3]Restricted Stock Units issued on March 1, 2023 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary of the date of grant that have converted to common stock on a one-for-one basis.
[F4]Restricted Stock Units issued on March 2, 2022 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary of the date of grant that have converted to common stock on a one-for-one basis.

Signature

/s/ Madison Gallagher, Attorney-in-Fact for Haydee Olinger|2026-03-02

1 file